Rogaska Slatina

Researchers are investigating how Helicobacter pylori infection is managed across Europe by collecting detailed information on diagnosis, treatment, and outcomes in routine clinical practice. H. pylori is a common infection linked to chronic gastritis, peptic ulcers, and gastric cancer, making its effective management important for reducing serious health problems and healthcare costs. This study aims to create a comprehensive database over one year that reflects real-world treatment approaches and adherence to clinical guidelines. The study is a non-intervention prospective registry involving up to ten gastroenterologists from 30 European countries. Each participating doctor will record information from their usual outpatient consultations of adult patients infected with H. pylori. Data collected includes patient demographics, symptoms, diagnostic tests, treatment regimens, drug dosages, treatment duration, adherence, side effects, and eradication success. This observational approach allows evaluation of current practices without altering patient care. Participants will receive routine clinical assessments as part of their care, with researchers gathering anonymized data through electronic case report forms. The study will analyze treatment effectiveness, safety, guideline adherence, and accessibility to diagnostic methods and medications. Outcomes measured include prescribed treatments over one year and eradication rates confirmed by tests. This registry supports ongoing improvements in managing H. pylori infection by providing a large, representative sample of European clinical practice.